Monday, June 09, 2014 7:11:20 PM
BY Midnight Trader — 5:51 PM ET 06/09/2014
http://stockcharts.com/h-sc/ui?s=RCPT
05:51 PM EDT, 06/09/2014 (MT Newswires) -- Receptos (RCPT) charged higher in Monday's after-hours trade after reporting its MS drug met the primary endpoint in a study.
RCPT was released from an after-hours halt and vaulted to a session high of 45.67. It scaled back the gains to maintain an upside range of 37.88 to 42.26 through the rest of the evening. A pre-market open Tuesday may have legs surrounding the 40 mark. A tentative near-term floor support formed Monday night at 38 up to 39, levels longs may want to eye as a possible base that could see lift back into the lower-40s.
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM